Monte Rosa Therapeutics Inc — Quarterly Financial Data (NASDAQ:GLUE) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Dividends per share ————— — Dividend yield % ————— — Payout ratio % ————— —

Haberler

Monte Rosa hisseleri prostat kanseri deneme sonuçlarıyla yükseldi

Monte Rosa shares rise on prostate cancer trial results

Monte Rosa prostat kanseri ilacı için olumlu deneme verisi açıkladı

Monte Rosa reports positive trial data for prostate cancer drug

NeoGenomics (NEO) Q4 Earnings and Revenues Surpass Estimates

Piper Sandler, Monte Rosa’nın hedef fiyatını 27,50 dolardan 37 dolara yükseltti

Monte Rosa stock price target raised to $37 from $27.50 at Piper Sandler

Monte Rosa Therapeutics 300 milyon dolarlık halka arz fiyatlandırmasını açıkladı

Monte Rosa Therapeutics prices $300 million public offering

GLUE Stock Up 45% on Positive Interim Data on Inflammation Drug

Monte Rosa Therapeutics (GLUE) is on the Move, Here's Why the Trend Could be Sustainable

Monte Rosa Therapeutics 200 milyon dolarlık halka arz başlatıyor